Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2022-02-11 Regulatory Filings
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2022-02-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd, announcing a strategic and exclusive agreement between Ajooni Biotech Limited and IFFCO KISAN Sanchar Ltd. It details the nature of the agreement, future plans for manufacturing and product development, and requests the information to be taken on record. There are no financial statements, regulatory certifications, voting results, or report publications mentioned. The content is an update on a business agreement and strategic partnership, which fits best under general regulatory announcements or compliance disclosures. Given the document length is short and it is an announcement rather than a detailed report, the most appropriate classification is Regulatory Filings (RNS).
2022-02-09 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd, informing about an upcoming Board Meeting scheduled for February 11, 2022. The agenda includes consideration and approval of unaudited financial results for the quarter ended December 31, 2021. The document is an announcement of a board meeting and does not contain actual financial data or results. It is a notification related to management activities, specifically about the board meeting and agenda items. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report or financial statement itself, so it is not an Interim/Quarterly Report (IR) or Earnings Release (ER).
2022-02-03 English
Updates
Regulatory Filings Classification · 95% confidence The document is a quarterly business update announcing sales figures and business developments for the quarter ending December 2021. It explicitly states that the data is subject to audit and is provided for information and records, indicating it is not a full interim or quarterly report with audited financial statements. The document is short (1508 characters) and serves as an announcement under SEBI regulations rather than a comprehensive financial report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-01-12 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended 31.12.2021. It is a formal attestation letter from the company secretary or registrar confirming compliance with regulatory requirements related to securities dematerialisation and listing. The document is short (1720 characters) and primarily a certification letter rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications and compliance documents that do not fit other categories.
2022-01-06 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (112 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any regulatory information. Given the lack of content, this cannot be classified as any substantive report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2021-12-31 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.